Group 1 - The number of shareholders for Changshan Pharmaceutical as of November 20 is 47,014, a decrease of 6,254 compared to the previous period, representing a decline of 11.74% [2] - The closing price of Changshan Pharmaceutical is 56.13 yuan, down 2.04%, with a cumulative increase of 5.35% since the concentration of shares began [2] - The latest margin trading data shows a total margin balance of 2.407 billion yuan as of November 20, with an increase of 90.46 million yuan, reflecting a growth of 3.90% [2] Group 2 - For the first three quarters, Changshan Pharmaceutical reported total operating revenue of 681 million yuan, a year-on-year decrease of 13.11%, and a net profit of -44.82 million yuan, a year-on-year decline of 714.77% [2] - The basic earnings per share for the company is -0.0500 yuan [2]
常山药业最新筹码趋于集中